Cystatin C predicts cognitive decline in multiple system atrophy: A 1-year prospective cohort study

BACKGROUND: Accumulating evidence has suggested that cystatin C is associated with cognitive impairment in patients with neurodegenerative diseases. However, the association between cystatin C and cognitive decline in patients with multiple system atrophy (MSA) remains largely unknown. OBJECTIVES: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lingyu, Li, Ruicen, Hou, Yanbing, Cao, Bei, Wei, Qianqian, Ou, Ruwei, Liu, Kuncheng, Lin, Junyu, Yang, Tianmi, Xiao, Yi, Huang, Wenxia, Shang, Huifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742413/
https://www.ncbi.nlm.nih.gov/pubmed/36518820
http://dx.doi.org/10.3389/fnagi.2022.1069837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742413/
https://www.ncbi.nlm.nih.gov/pubmed/36518820
http://dx.doi.org/10.3389/fnagi.2022.1069837

Ejemplares similares